Transcripts - Larry Biegelsen Good afternoon. I’m Larry Biegelsen, the medical device analyst at Wells Fargo. And it’s my pleasure to host this session with DexCom. With … Continue Reading
Read nowRecap - Investors descend en masse on San Francisco next week for the annual JP Morgan healthcare conference, a major event for the sector that historically generates … Continue Reading
Read nowInsights - Endo Health (ENDP) and Auxilium Pharmaceuticals (AUXL) finally came to terms in ongoing buyout negotiations, with ENDP handing over $2.6 billion ($33.25 per share) in … Continue Reading
Read nowRecap - It looked briefly at mid-week like the biotech sector’s correction might be a comical 48-hour event, but investors are in a tizzy over the emerging … Continue Reading
Read nowLong Ideas - Shares of ViroPharma soared by 25% on Friday as Bloomberg reported that the drug developer has hired Goldman Sachs to explore takeover offers following interest … Continue Reading
Read nowLong Ideas - Targeted therapies are the oncologists’ precision tool in treating difficult cancers. Where early therapeutics like radiotherapy and chemotherapy tackle cancers by bombarding all rapidly dividing … Continue Reading
Read nowLong Ideas - On Tuesday, the FDA ruled that generic drug-makers are barred from selling copies of older, easily abused formulations of Purdue Pharma’s well-known pain killer OxyContin, … Continue Reading
Read now
